• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EZH2通过对EAF2-HIF1α信号通路的表观遗传抑制促进胶质母细胞瘤中的代谢重编程。

EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling.

作者信息

Pang Bo, Zheng Xiang-Rong, Tian Jing-Xia, Gao Tai-Hong, Gu Guang-Yan, Zhang Rui, Fu Yi-Bing, Pang Qi, Li Xin-Gang, Liu Qian

机构信息

Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.

Department of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China.

出版信息

Oncotarget. 2016 Jul 19;7(29):45134-45143. doi: 10.18632/oncotarget.9761.

DOI:10.18632/oncotarget.9761
PMID:27259264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5216711/
Abstract

Cancer cells prefer glycolysis for energy metabolism, even when there is sufficient oxygen to make it unnecessary. This is called the Warburg effect, and it promotes tumorigenesis and malignant progression. In this study, we demonstrated that EZH2, a multifaceted oncogenic protein involved in tumor proliferation, invasion and metastasis, promotes glioblastoma tumorigenesis and malignant progression through activation of the Warburg effect. We observed that HIF1α is a target of EZH2 whose activation is necessary for EZH2-mediated metabolic adaption, and that HIF1α is activated upon EZH2 overexpression. EZH2 suppressed expression of EAF2, which in turn upregulated HIF1α levels. We conclude from these results that EZH2 promotes tumorigenesis and malignant progression in part by activating glycolysis through an EAF2-HIF1α signaling axis.

摘要

癌细胞即使在有足够氧气使其无需进行糖酵解的情况下,仍倾向于通过糖酵解进行能量代谢。这被称为瓦伯格效应,它会促进肿瘤发生和恶性进展。在本研究中,我们证明了EZH2(一种参与肿瘤增殖、侵袭和转移的多面致癌蛋白)通过激活瓦伯格效应促进胶质母细胞瘤的肿瘤发生和恶性进展。我们观察到HIF1α是EZH2的一个靶点,其激活对于EZH2介导的代谢适应是必需的,并且在EZH2过表达时HIF1α被激活。EZH2抑制EAF2的表达,进而上调HIF1α水平。我们从这些结果得出结论,EZH2部分通过EAF2-HIF1α信号轴激活糖酵解来促进肿瘤发生和恶性进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee20/5216711/67ae03a6443b/oncotarget-07-45134-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee20/5216711/dd858832faa3/oncotarget-07-45134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee20/5216711/5ecc166292f0/oncotarget-07-45134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee20/5216711/ab35f5160101/oncotarget-07-45134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee20/5216711/4e33a0fedb24/oncotarget-07-45134-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee20/5216711/67ae03a6443b/oncotarget-07-45134-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee20/5216711/dd858832faa3/oncotarget-07-45134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee20/5216711/5ecc166292f0/oncotarget-07-45134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee20/5216711/ab35f5160101/oncotarget-07-45134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee20/5216711/4e33a0fedb24/oncotarget-07-45134-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee20/5216711/67ae03a6443b/oncotarget-07-45134-g005.jpg

相似文献

1
EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling.EZH2通过对EAF2-HIF1α信号通路的表观遗传抑制促进胶质母细胞瘤中的代谢重编程。
Oncotarget. 2016 Jul 19;7(29):45134-45143. doi: 10.18632/oncotarget.9761.
2
FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway.FOXC1 介导的 LINC00301 通过调节 HIF1α 通路促进非小细胞肺癌的肿瘤进展并触发免疫抑制微环境。
Genome Med. 2020 Sep 2;12(1):77. doi: 10.1186/s13073-020-00773-y.
3
Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma.EZH2/miRNA/β-连环蛋白信号通路的破坏抑制胶质瘤中的有氧糖酵解。
Oncotarget. 2016 Aug 2;7(31):49450-49458. doi: 10.18632/oncotarget.10370.
4
Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.EZH2 表达对脑胶质瘤细胞增殖和致瘤性的影响。
Med Sci Monit. 2018 Oct 11;24:7249-7255. doi: 10.12659/MSM.909814.
5
GRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1α destabilization.GRIM-19 通过降解 HIF1α 来抑制胶质母细胞瘤细胞代谢的重编程。
Carcinogenesis. 2013 Aug;34(8):1728-36. doi: 10.1093/carcin/bgt125. Epub 2013 Apr 11.
6
E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression.E2F7-EZH2 轴调节 PTEN/AKT/mTOR 信号通路并促进胶质母细胞瘤进展。
Br J Cancer. 2020 Oct;123(9):1445-1455. doi: 10.1038/s41416-020-01032-y. Epub 2020 Aug 20.
7
PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration.PRMT6 通过抑制 TRAF6 介导的泛素化降解促进 EZH2 蛋白稳定性,从而促进脑胶质母细胞瘤细胞的侵袭和迁移。
Cell Death Dis. 2024 Jul 23;15(7):524. doi: 10.1038/s41419-024-06920-2.
8
Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α.缺氧激活的 XBP1s 招募 HDAC2-EZH2 以参与 ΔNp63α 表达的表观遗传抑制,并独立于 HIF1α 促进乳腺癌转移。
Cell Death Differ. 2024 Apr;31(4):447-459. doi: 10.1038/s41418-024-01271-z. Epub 2024 Feb 27.
9
Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.EZH2通过miR-181b/HK2轴参与前列腺癌的有氧糖酵解过程。
Oncol Rep. 2017 Mar;37(3):1430-1436. doi: 10.3892/or.2017.5430. Epub 2017 Feb 7.
10
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.EZH2 在恶性神经胶质瘤和神经胶质瘤干细胞中呈上调表达。
Neuropathol Appl Neurobiol. 2011 Jun;37(4):381-94. doi: 10.1111/j.1365-2990.2010.01132.x.

引用本文的文献

1
Epigenetic regulation of histone modifications in glioblastoma: recent advances and therapeutic insights.胶质母细胞瘤中组蛋白修饰的表观遗传调控:最新进展与治疗见解
Biomark Res. 2025 May 31;13(1):80. doi: 10.1186/s40364-025-00788-w.
2
Polycomb repressive complex 2 (PRC2) pathway's role in cancer cell plasticity and drug resistance.多梳抑制复合物2(PRC2)通路在癌细胞可塑性和耐药性中的作用。
Funct Integr Genomics. 2025 Mar 6;25(1):53. doi: 10.1007/s10142-025-01563-8.
3
Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential.

本文引用的文献

1
Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.靶向EZH2通过调节头颈部鳞状细胞癌中线粒体依赖性细胞死亡途径来调控肿瘤生长和细胞凋亡。
Oncotarget. 2015 Oct 20;6(32):33720-32. doi: 10.18632/oncotarget.5606.
2
12-Deoxyphorbol 13-palmitate inhibits the expression of VEGF and HIF-1α in MCF-7 cells by blocking the PI3K/Akt/mTOR signaling pathway.12-脱氧佛波醇13-棕榈酸酯通过阻断PI3K/Akt/mTOR信号通路抑制MCF-7细胞中VEGF和HIF-1α的表达。
Oncol Rep. 2015 Oct;34(4):1755-60. doi: 10.3892/or.2015.4166. Epub 2015 Jul 31.
3
Prognostic value of polycomb proteins EZH2, BMI1 and SUZ12 and histone modification H3K27me3 in colorectal cancer.
癌症中靶向EZH2:机制、途径及治疗潜力
Molecules. 2024 Dec 10;29(24):5817. doi: 10.3390/molecules29245817.
4
Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets.脑胶质瘤中代谢重编程:通路与治疗靶点综述。
Cells. 2024 Sep 19;13(18):1574. doi: 10.3390/cells13181574.
5
Hypoxia makes EZH2 inhibitor not easy-advances of crosstalk between HIF and EZH2.缺氧使EZH2抑制剂作用受阻——HIF与EZH2相互作用的研究进展
Life Metab. 2024 Aug;3(4). doi: 10.1093/lifemeta/loae017. Epub 2024 May 6.
6
The function of histone methylation and acetylation regulators in GBM pathophysiology.组蛋白甲基化和乙酰化调节因子在胶质母细胞瘤病理生理学中的作用。
Front Oncol. 2023 May 2;13:1144184. doi: 10.3389/fonc.2023.1144184. eCollection 2023.
7
Metabolic Rewiring in Adult-Type Diffuse Gliomas.成人型弥漫性神经胶质瘤中的代谢重编程。
Int J Mol Sci. 2023 Apr 16;24(8):7348. doi: 10.3390/ijms24087348.
8
Zebrafish ELL-associated factors Eaf1/2 modulate erythropoiesis via regulating gata1a expression and WNT signaling to facilitate hypoxia tolerance.斑马鱼ELL相关因子Eaf1/2通过调节gata1a表达和WNT信号通路来调节红细胞生成,以促进缺氧耐受性。
Cell Regen. 2023 Apr 1;12(1):10. doi: 10.1186/s13619-022-00154-3.
9
Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies.组蛋白修饰及其在血液系统恶性肿瘤中的治疗靶点的影响。
Int J Mol Sci. 2022 Nov 7;23(21):13657. doi: 10.3390/ijms232113657.
10
Overexpression of ELL-associated factor 2 suppresses invasion, migration, and angiogenesis in colorectal cancer.ELL相关因子2的过表达抑制结直肠癌的侵袭、迁移和血管生成。
World J Gastrointest Oncol. 2022 Oct 15;14(10):1949-1967. doi: 10.4251/wjgo.v14.i10.1949.
多梳蛋白EZH2、BMI1和SUZ12以及组蛋白修饰H3K27me3在结直肠癌中的预后价值
PLoS One. 2014 Sep 22;9(9):e108265. doi: 10.1371/journal.pone.0108265. eCollection 2014.
4
EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.EZH2 依赖性 H3K27me3 参与前列腺癌中 ID4 的表观遗传沉默。
Oncotarget. 2014 Aug 30;5(16):7172-82. doi: 10.18632/oncotarget.2262.
5
Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma.zeste 同源物2增强子(EZH2)通过对肾细胞癌中E-钙黏蛋白的表观遗传抑制促进肿瘤细胞迁移和侵袭。
BJU Int. 2016 Feb;117(2):351-62. doi: 10.1111/bju.12702. Epub 2015 Apr 21.
6
EAF2 suppresses hypoxia-induced factor 1α transcriptional activity by disrupting its interaction with coactivator CBP/p300.EAF2 通过破坏其与共激活因子 CBP/p300 的相互作用来抑制缺氧诱导因子 1α 的转录活性。
Mol Cell Biol. 2014 Mar;34(6):1085-99. doi: 10.1128/MCB.00718-13. Epub 2014 Jan 13.
7
Polycomb repressive complex 2 contributes to DNA double-strand break repair.多梳抑制复合物 2 有助于 DNA 双链断裂修复。
Cell Cycle. 2013 Aug 15;12(16):2675-83. doi: 10.4161/cc.25795. Epub 2013 Jul 29.
8
Epigenetic silencing of Bim transcription by Spi-1/PU.1 promotes apoptosis resistance in leukaemia.Spi-1/PU.1 介导的 Bim 转录的表观遗传沉默促进白血病细胞的抗凋亡。
Cell Death Differ. 2013 Sep;20(9):1268-78. doi: 10.1038/cdd.2013.88. Epub 2013 Jul 12.
9
Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.EAF2/U19 与 Pten 同时缺失协同促进小鼠模型前列腺癌的发生。
Oncogene. 2014 May 1;33(18):2286-94. doi: 10.1038/onc.2013.190. Epub 2013 May 27.
10
von Hippel-Lindau syndrome.von Hippel-Lindau 综合征。
Front Horm Res. 2013;41:30-49. doi: 10.1159/000345668. Epub 2013 Mar 19.